EMA — authorised 18 September 2017
- Marketing authorisation holder: Novartis Europharm Ltd
- Status: approved
🇪🇺 Rydapt in European Union
EMA authorised Rydapt on 18 September 2017
Marketing authorisation
Rydapt in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Rydapt approved in European Union?
Yes. EMA authorised it on 18 September 2017.
Who is the marketing authorisation holder for Rydapt in European Union?
Novartis Europharm Ltd holds the EU marketing authorisation.